Charles River Laboratories International, Inc.

New York Stock Exchange
Back to all articles
Neutral 0

“CNBC CURES: DEFYING RARE DISEASE” WITH BECKY QUICK TO PREMIERE ON THURSDAY, MARCH 19 AT 7PM ET

AI-generated analysis

🎬 CNBC will debut a one-hour special titled "CNBC Cures: Defying Rare Disease" on Thursday, March 19 at 7PM ET.

👩‍💻 The program is hosted by Becky Quick, who shares her family's personal battle with her daughter's rare disease.

🧬 The special spotlights families affected by rare diseases and the innovators working to improve their futures.

💊 It highlights the gap between scientific advances and the ongoing issues of funding, access, and support for patients.

🗣️ Guests include GeneDx CEO Katherine Stueland, n-Lorem Founder Dr. Stanley Crooke, former FDA Commissioner Dr. Scott Gottlieb, and Biotechnology Innovation Organization President John Crowley.

🏥 Interviews also feature executives from Charles River Laboratories, Cure Rare Disease, physicians from the Children's Hospital of Philadelphia, and "Beast Games" winner Jeffrey Allen.

📺 CNBC is a global leader in business and financial news reaching half a billion people monthly across platforms.

💻 The network offers content through live TV, digital destinations like CNBC.com, and subscription services including CNBC+ and CNBC Pro.

📱 Audiences can access premium content via live events, podcasts, newsletters, and social media channels.

📩 CNBC is seeking confidential news tips from the public regarding rare disease developments.

Bullish Signals
  • The special will premiere on Thursday, March 19 at 7PM ET, providing timely coverage of rare disease innovation.
  • Hosted by Becky Quick, the program features exclusive interviews with leading industry leaders including GeneDx CEO Katherine Stueland and former FDA Commissioner Dr. Scott Gottlieb.
  • CNBC reaches half a billion people every month across all platforms, offering broad reach for the in-depth reporting.
  • The special highlights innovators fighting to change patient futures, showcasing positive progress in scientific advances.
  • Audiences can access premium content through various CNBC+ and digital destinations to stay informed on market-moving forces.
Risk Factors
  • The special reveals stark reality of patients caught between groundbreaking scientific advances and persistent gaps in funding, access, and support, highlighting unresolved systemic challenges.
  • Rising capital expenditure in medical research may be outpacing available funding for rare disease treatments as noted by the stark reality described in the program.
Full Analysis
CNBC will debut an in-depth, one-hour special titled "CNBC Cures: Defying Rare Disease" on Thursday, March 19 at 7PM ET. Hosted by Becky Quick, the program will move beyond the anchor desk to explore her family's personal struggle with her daughter's rare disease, providing a human perspective on the challenges faced by patients navigating groundbreaking scientific advances versus persistent gaps in funding and access. The special is designed to spotlight families dealing with rare diseases alongside scientists, advocates, and innovators working to change their futures. The program features exclusive interviews with prominent industry figures including GeneDx CEO Katherine Stueland, n-Lorem Founder & CEO Dr. Stanley Crooke, former FDA Commissioner Dr. Scott Gottlieb, Charles River Laboratories President & CEO Jim Foster, Biotechnology Innovation Organization President & CEO John Crowley, and Cure Rare Disease Founder & CEO Rich Horgan. In addition to these leaders, the special will include insights from physicians at the Children's Hospital of Philadelphia, Beast Games winner Jeffrey Allen, and various families navigating rare diseases who are actively advocating for their community. CNBC promotes itself as a global leader in business and financial news reaching half a billion people monthly across platforms including live TV, CNBC.com, digital subscriptions like CNBC+ and CNBC Select, and mobile apps. The network describes its mission as helping business leaders and investors make informed decisions while covering real-time market data and breaking news from headquarters in the U.S., Europe, and Asia. The special will air on Thursday, March 19 at 7PM ET according to Eastern Time.